Discontinue lamotrigine immediately in this patient with ongoing hypomania
Given the patient's active hypomanic symptoms while on lamotrigine 200 mg daily, you should stop lamotrigine abruptly rather than taper it. Lamotrigine lacks antimanic properties and may be contributing to the mood destabilization through its antidepressant effects 1.
Clinical Reasoning
Why Immediate Discontinuation is Appropriate
Lamotrigine can induce or worsen manic/hypomanic episodes, particularly in patients with:
- Bipolar I disorder
- Manic predominant polarity
- History of antidepressant-induced switches
- Current manic/hypomanic symptoms 1
The evidence shows that lamotrigine-induced mania typically resolves within 7-10 days of discontinuation 1. In documented cases, patients experienced rapid remission (within 1 week to 10 days) after lamotrigine withdrawal, even without aggressive antimanic treatment escalation.
No Taper Required for Safety
Unlike benzodiazepines or certain other psychotropics, lamotrigine does not require gradual tapering for safety when discontinuing. The gradual titration schedule used when starting lamotrigine (to prevent Stevens-Johnson syndrome) is irrelevant when stopping the medication. There is no withdrawal syndrome or medical danger from abrupt lamotrigine cessation.
Drug Interaction Consideration
The patient is receiving aripiprazole, which has no clinically significant interaction with lamotrigine 2. However, note that lamotrigine at doses >200 mg/day can reduce quetiapine levels by 46% if the patient were on that medication instead 3.
Management Algorithm
- Stop lamotrigine immediately - no taper needed
- Optimize aripiprazole dosing for antimanic effect (the patient is already on an appropriate agent)
- Monitor closely - expect hypomanic symptoms to resolve within 7-10 days 1
- Do not restart lamotrigine in this patient given the clear temporal relationship between lamotrigine use and mood destabilization
Critical Pitfall to Avoid
Do not attempt a slow taper thinking it will be "safer" - this only prolongs exposure to a medication that is actively worsening the patient's mood state. The risk of Stevens-Johnson syndrome is associated with starting lamotrigine too quickly, not with stopping it.